{
    "clinical_study": {
        "@rank": "1537", 
        "arm_group": {
            "arm_group_label": "Growth hormone, injections", 
            "arm_group_type": "Experimental", 
            "description": "Growth hormone injection 0.3mg/kg/week dailY"
        }, 
        "brief_summary": {
            "textblock": "The purpose of the study is to evaluate the predictive value of IGF-1 generation test for\n      growth velocity during GH treatment for 12 months."
        }, 
        "brief_title": "The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Short Stature", 
        "condition_browse": {
            "mesh_term": "Dwarfism"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ability to provide written informed consent\n\n          -  Prepubertal males and females form 5- 11years old\n\n          -  Bone age <11 years in males and <9 years in females\n\n          -  Height SD score<-2.25SD in males and females\n\n          -  IGF-1SD score <-1SD in both males and females\n\n          -  Peak GH level after stimulation >10ng/ml\n\n        Exclusion Criteria:\n\n          -  History of prior chemotherapy and or radiation\n\n          -  Active neoplasm\n\n          -  Pediatric patients with closed epiphyses\n\n          -  Prader-Willi syndrome, Turner syndrome or any other genetic or chromosomal anomaly\n\n          -  Treatment with inhaled or systemic steroids\n\n          -  BMI <5th percentile or >95th percentile\n\n          -  Tanner 2 at clinical or biochemical examination by ultrasensitive LH and FSH"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "11 Years", 
            "minimum_age": "5 Years"
        }, 
        "enrollment": {
            "#text": "35", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01970800", 
            "org_study_id": "10/01/VA03"
        }, 
        "intervention": {
            "arm_group_label": "Growth hormone, injections", 
            "description": "Will obtain daily injections and will evaluate the IGF-1 and IGFBP3 every 3 months", 
            "intervention_name": "Growth Hormone", 
            "intervention_type": "Drug", 
            "other_name": "Nutropin AQ"
        }, 
        "intervention_browse": {
            "mesh_term": "Hormones"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "IGF-1", 
            "Short Stature", 
            "GH"
        ], 
        "lastchanged_date": "October 25, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Brooklyn", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "11219"
                }, 
                "name": "Maimonides Medical Center"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature", 
        "overall_contact": {
            "email": "tenlana@aol.com", 
            "last_name": "Svetlana Ten, MD", 
            "phone": "718-283-8894"
        }, 
        "overall_official": {
            "affiliation": "Maimonides Medical Center", 
            "last_name": "Svetlana Ten, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Growth velocity after treatment with appropriate growth hormone doses", 
            "measure": "Primary Efficacy Outcome measurement", 
            "safety_issue": "Yes", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01970800"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Maimonides Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Maimonides Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}